In the representative case (patient 1; Supplemental Table 1) with positive 68Ga-grazytracer PET/CT results after 3 cycles of chemotherapy plus anti–PD-1 immunotherapy, 18F-FDG revealed decreased tumor uptake in the follow-up PET/CT examination (Figure 7A). This evidence concerns the gene PDCD1 and neoplasm.